Mergers & Acquisitions

Vedanta Limited: Acquisition of Debt and Controlling Equity Stake in AvanStrate by a Wholly Owned Subsidiary of Vedanta Limited

Vedanta Limited: Acquisition of Debt and Controlling Equity Stake in AvanStrate by a Wholly Owned Subsidiary of Vedanta Limited PR Newswire MUMBAI, Dec. 27, 2017 MUMBAI , Dec. 27, 2017 /PRNewswire/ — The Board of Directors of Vedanta Limited’s (Vedanta) wholly owned subsidiary, Cairn India holdings Limited (CIHL), have approved an investment of c […]

Momentum Stocks

Bull of the Day: Winnebago (WGO)

Winnebago Industries, Inc. ( WGO ) is cashing in on the strong employment and stock markets as its towable products remain in strong demand. This Zacks Rank #1 (Strong Buy) stock is expected to see double digit revenue growth in fiscal 2018. […]

Stock Analysts

Portola’s (PTLA) AndexXa BLA Review Period Extended by FDA

Portola Pharmaceuticals, Inc. PTLA announced that the FDA has extended the review period of its biologics license application (BLA) for the reversal agent of Factor Xa inhibitors, AndexXa (andexanet alfa), by 90 days. As a result, the regulatory body will now announce its decision by May 4, 2018 instead of the previously set deadline of Feb 3, 2018. […]

Stock Analysts

U.S. Telecommunications Industry — Looking Forward to 2018

It is turning out to be disappointing 2017 for the U.S. telecommunications industry. Cut-throat pricing competition resulting in lower ARPU (average revenue per user) and margins, massive investment for upcoming 5G wireless network and fiber optic buildout resulting in low free cash flow and intense competitive pressure shifted investor’s focus toward other growth-oriented industries in an overall bull market in 2017 […]

Stock Analysts

BioMarin’s (BMRN) Pegvaliase Review Period Extended by FDA

BioMarin Pharmaceutical Inc. BMRN announced that the FDA has extended the review period of its biologics license application (BLA) for its investigational therapy, pegvaliase, by three months to May 25, 2018. Currently, the company is looking to get pegvaliase approved for lowering blood phenylalanine (Phe) levels in adults with phenylketonuria (PKU), a rare genetic enzyme deficiency disorder, having uncontrolled blood Phe levels with existing treatment options. […]

Technicals

New Strong Sell Stocks for December 26th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: Wesco Aircraft Holdings, Inc. WAIR is a distributor of aerospace bearing products and provides supply chain management services. The Zacks Consensus Estimate for its current year earnings has been revised 16.9% downward over the last 30 days […]

Stock Analysts

Clorox Hits 52-Week High: Will the Uptrend Continue in 2018?

The Clorox Company CLX looks attractive on the back of its brand management initiatives, focus on e-commerce model and 2020 Strategy. Also, the company has delivered a robust start to fiscal 2018 as both first-quarter earnings and sales topped estimates and improved year over year. Consequently, the stock scaled a 52-week high $149.90 on Dec 22, though it closed a tad lower at $149.52. […]